Disorazoles Block Group A Streptococcal Invasion into Epithelial Cells Via Interference with the Host Factor Ezrin

Cell Chemical Biology - Tập 24 - Trang 159-170 - 2017
Katharina Rox1,2,3,4, Manfred Rohde2, Gursharan Singh Chhatwal3, Rolf Müller1,4
1Department of Microbial Natural Products (MINS), Helmholtz Institute for Pharmaceutical Research Saarland (HIPS) - Helmholtz Centre for Infection Research (HZI) and Institute for Pharmaceutical Biotechnology, Saarland University, 66123 Saarbrücken, Germany
2Central Facility for Microscopy (ZEIM), Helmholtz Centre for Infection Research (HZI), 38124 Braunschweig, Germany
3Department of Medical Microbiology (MMIK), Helmholtz Centre for Infection Research (HZI), 38124 Braunschweig, Germany
4German Centre for Infection Research (DZIF), Partner Site Braunschweig-Hannover, Hannover, Germany

Tài liệu tham khảo

Aicher, 2011, Abstract C214: disorazol Z: a highly cytotoxic natural compound with antitumor properties, Mol. Cancer Ther., 10, C214, 10.1158/1535-7163.TARG-11-C214 Baumann, 2014, Cystobactamids: myxobacterial topoisomerase inhibitors exhibiting potent antibacterial activity, Angew. Chem. Int. Ed. Engl., 53, 14605, 10.1002/anie.201409964 Berryman, 1993, Ezrin is concentrated in the apical microvilli of a wide variety of epithelial cells whereas moesin is found primarily in endothelial cells, J. Cell Sci., 105, 1025, 10.1242/jcs.105.4.1025 Bretscher, 1989, Rapid phosphorylation and reorganization of ezrin and spectrin accompany morphological changes induced in A-431 cells by epidermal growth factor, J. Cell Biol., 108, 921, 10.1083/jcb.108.3.921 Bretscher, 1997, Ezrin: a protein requiring conformational activation to link microfilaments to the plasma membrane in the assembly of cell surface structures, J. Cell Sci., 110, 3011, 10.1242/jcs.110.24.3011 Bretscher, 2002, ERM proteins and merlin: integrators at the cell cortex, Nat. Rev. Mol. Cell Biol., 3, 586, 10.1038/nrm882 Bulut, 2012, Small molecule inhibitors of ezrin inhibit the invasive phenotype of osteosarcoma cells, Oncogene, 31, 269, 10.1038/onc.2011.245 Carapetis, 2005, The global burden of group A streptococcal diseases, Lancet Infect. Dis., 5, 685, 10.1016/S1473-3099(05)70267-X Clatworthy, 2007, Targeting virulence: a new paradigm for antimicrobial therapy, Nat. Chem. Biol., 3, 541, 10.1038/nchembio.2007.24 Cragg, 2014, New horizons for old drugs and drug leads, J. Nat. Prod., 77, 703, 10.1021/np5000796 Cue, 1998, Streptococcus pyogenes serotype M1 encodes multiple pathways for entry into human epithelial cells, Infect. Immun., 66, 4593, 10.1128/IAI.66.10.4593-4601.1998 Cue, 2000, A nonpetide integrin antagonist can inhibit epithelial cell ingestion of Streptococcus pyogenes by blocking formation of integrin α5β1-fibronectin-M1 protein complexes, Proc. Natl. Acad. Sci. USA, 97, 2858, 10.1073/pnas.050587897 Cywes, 2001, Group A Streptococcus tissue invasion by CD44-mediated cell signalling, Nature, 414, 648, 10.1038/414648a Efstratiou, 2016, Epidemiology of Streptococcus pyogenes Elnakady, 2004, Disorazol A1, a highly effective antimitotic agent acting on tubulin polymerization and inducing apoptosis in mammalian cells, Biochem. Pharmacol., 67, 927, 10.1016/j.bcp.2003.10.029 Fais, 2004, A role for ezrin in a neglected metastatic tumor function, Trends Mol. Med., 10, 249, 10.1016/j.molmed.2004.04.005 Fais, 2007, Cannibalism: a way to feed on metastatic tumors, Cancer Lett., 258, 155, 10.1016/j.canlet.2007.09.014 Fievet, 2004, Phosphoinositide binding and phosphorylation act sequentially in the activation mechanism of ezrin, J. Cell Biol., 164, 653, 10.1083/jcb.200307032 Franck, 1993, Moesin, like ezrin, colocalizes with actin in the cortical cytoskeleton in cultured cells, but its expression is more variable, J. Cell Sci., 105, 219, 10.1242/jcs.105.1.219 Gautreau, 2000, Morphogenic effects of ezrin require a phosphorylation-induced transition from oligomers to monomers at the plasma membrane, J. Cell Biol., 150, 193, 10.1083/jcb.150.1.193 Gerth, 1996, Epothilons A and B: antifungal and cytotoxic compounds from Sorangium cellulosum (Myxobacteria). Production, physico-chemical and biological properties, J. Antibiot. (Tokyo), 49, 560, 10.7164/antibiotics.49.560 Gerth, 2003, Myxobacteria: proficient producers of novel natural products with various biological activities—past and future biotechnological aspects with the focus on the genus Sorangium, J. Biotechnol., 106, 233, 10.1016/j.jbiotec.2003.07.015 Günther, E., Schaefer, O., Teifel, M., and Paulini, K.. (2008). Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole derivatives, processes of manufacturing and uses thereof. WO Patent Number WO2008028934 A8. Henningham, 2012, Conserved anchorless surface proteins as group A streptococcal vaccine candidates, J. Mol. Med., 90, 1197, 10.1007/s00109-012-0897-9 Hirao, 1996, Regulation mechanism of ERM (ezrin/radixin/moesin) protein/plasma membrane association: possible involvement of phosphatidylinositol turnover and Rho-dependent signaling pathway, J. Cell Biol., 135, 37, 10.1083/jcb.135.1.37 Högberg, 2010, The global need for effective antibiotics: challenges and recent advances, Trends Pharmacol. Sci., 31, 509, 10.1016/j.tips.2010.08.002 Hopkins, 2009, Isolation, biology and chemistry of the disorazoles: new anti-cancer macrodiolides, Nat. Prod. Rep., 26, 585, 10.1039/b813799b Hunter, 2004, Ezrin, a key component in tumor metastasis, Trends Mol. Med., 10, 201, 10.1016/j.molmed.2004.03.001 Jansen, 1994, Antibiotics from gliding bacteria, LIX. Disorazoles, highly cytotoxic metabolites from the sorangicin-producing bacterium Sorangium cellulosum, strain So ce12, Liebigs Ann. Chem., 1994, 759, 10.1002/jlac.199419940802 Kaplan, 2006, Reduced ability of penicillin to eradicate ingested group A streptococci from epithelial cells: clinical and pathogenetic implications, Clin. Infect. Dis., 43, 1398, 10.1086/508773 Khalil, 2006, Mechanism of action of tubulysin, an antimitotic peptide from myxobacteria, ChemBioChem, 7, 678, 10.1002/cbic.200500421 Khanna, 2004, The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis, Nat. Med., 10, 182, 10.1038/nm982 Koutsoudakis, 2015, Soraphen A: a broad-spectrum antiviral natural product with potent anti-hepatitis C virus activity, J. Hepatol., 63, 813, 10.1016/j.jhep.2015.06.002 Lu, 2012, An overview of tubulin inhibitors that interact with the colchicine binding site, Pharm. Res., 29, 2943, 10.1007/s11095-012-0828-z Molinari, 1997, The fibronectin-binding protein of Streptococcus pyogenes, SfbI, is involved in the internalization of group A streptococci by epithelial cells, Infect. Immun., 65, 1357, 10.1128/IAI.65.4.1357-1363.1997 Molinari, 2000, Two distinct pathways for the invasion of Streptococcus pyogenes in non-phagocytic cells, Cell. Microbiol., 2, 145, 10.1046/j.1462-5822.2000.00040.x Müller, 2014, Future potential for anti-infectives from bacteria – how to exploit biodiversity and genomic potential, Int. J. Med. Microbiol., 304, 3, 10.1016/j.ijmm.2013.09.004 Neeman, 1998, Prevalence of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers, Lancet, 352, 1974, 10.1016/S0140-6736(97)12452-7 Newman, 2007, Natural products as sources of new drugs over the last 25 years, J. Nat. Prod., 70, 461, 10.1021/np068054v Newman, 2012, Natural products as sources of new drugs over the 30 years from 1981 to 2010, J. Nat. Prod., 75, 311, 10.1021/np200906s Ogawa, 2011, Biofilm formation or internalization into epithelial cells enable Streptococcus pyogenes to evade antibiotic eradication in patients with pharyngitis, Microb. Pathog., 51, 58, 10.1016/j.micpath.2011.03.009 Österlund, 1997, Intracellular reservoir of Streptococcus pyogenes in vivo: a possible explanation for recurrent pharyngotonsillitis, Laryngoscope, 107, 640, 10.1097/00005537-199705000-00016 Ozeri, 2001, De novo formation of focal complex-like structures in host cells by invading Streptococci, Mol. Microbiol., 41, 561, 10.1046/j.1365-2958.2001.02535.x Paige, 2014, Design, synthesis and biological evaluation of ezrin inhibitors targeting metastatic osteosarcoma, Bioorg. Med. Chem., 22, 478, 10.1016/j.bmc.2013.11.003 Pandey, 2016, Combinatorial synthetic peptide vaccine strategy protects against hypervirulent CovR/S mutant streptococci, J. Immunol., 15, 3364, 10.4049/jimmunol.1501994 Purushothaman, 2003, M1 protein triggers a phosphoinositide cascade for group A Streptococcus invasion of epithelial cells, Infect. Immun., 71, 5823, 10.1128/IAI.71.10.5823-5830.2003 Rohde, 2013, Adherence and invasion of streptococci to eukaryotic cells and their role in disease pathogenesis, Curr. Top. Microbiol. Immunol., 368, 83 Rohde, 2003, Host cell caveolae act as an entry-port for group A streptococci, Cell. Microbiol., 5, 323, 10.1046/j.1462-5822.2003.00279.x Rohde, 2011, Differences in the aromatic domain of homologous streptococcal fibronectin-binding proteins trigger different cell invasion mechanisms and survival rates: streptococcal fibronectin-binding proteins, Cell. Microbiol., 13, 450, 10.1111/j.1462-5822.2010.01547.x Sanderson-Smith, 2014, A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development, J. Infect. Dis., 210, 1325, 10.1093/infdis/jiu260 Schoenwaelder, 1999, Bidirectional signaling between the cytoskeleton and integrins, Curr. Opin. Cell Biol., 11, 274, 10.1016/S0955-0674(99)80037-4 Seitz, 2014, Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125, BMC Cancer, 14, 847, 10.1186/1471-2407-14-847 Trédan, 2015, Ixabepilone alone or with cetuximab as first-line treatment for advanced/metastatic triple-negative breast cancer, Clin. Breast Cancer, 15, 8, 10.1016/j.clbc.2014.07.007 Tsukita, 1997, ERM proteins: head-to-tail regulation of actin-plasma membrane interaction, Trends Biochem. Sci., 22, 53, 10.1016/S0968-0004(96)10071-2 Tsukita, 1997, ERM (ezrin/radixin/moesin) family: from cytoskeleton to signal transduction, Curr. Opin. Cell Biol., 9, 70, 10.1016/S0955-0674(97)80154-8 Vaheri, 1997, The ezrin protein family: membrane-cytoskeleton interactions and disease associations, Curr. Opin. Cell Biol., 9, 659, 10.1016/S0955-0674(97)80119-6 Viswanatha, 2014, Dynamics of ezrin and EBP50 in regulating microvilli on the apical aspect of epithelial cells, Biochem. Soc. Trans., 42, 189, 10.1042/BST20130263 Walden, 2015, An internal thioester in a pathogen surface protein mediates covalent host binding, Elife, 4, e06638, 10.7554/eLife.06638 Walker, 2014, Disease manifestations and pathogenic mechanisms of group A Streptococcus, Clin. Microbiol. Rev., 27, 264, 10.1128/CMR.00101-13 Wang, 2006, Integrin-linked kinase is an essential link between integrins and uptake of bacterial pathogens by epithelial cells, Cell. Microbiol., 8, 257, 10.1111/j.1462-5822.2005.00618.x Wang, 2007, Paxillin phosphorylation: bifurcation point downstream of integrin-linked kinase (ILK) in streptococcal invasion, Cell. Microbiol., 9, 1519, 10.1111/j.1462-5822.2007.00889.x Yu, 2004, Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators, Nat. Med., 10, 175, 10.1038/nm966 Zhang, 2014, Osteosarcoma metastasis: prospective role of ezrin, Tumor Biol., 35, 5055, 10.1007/s13277-014-1799-y